Suministro de asociación de Levodopa/Carbidopa (DOE) gel intestinal, asociación Foslevodopa/Foscarbidopa (DOE) y Risankizumab (DOE)
Awarded
The competition has ended and a winner has been selected.
- Procedure
- Without prior noticeTwo stages
- Agreement
- Buying goods
- Estimated value
- €29.4Mover 5 years
Brief
Osakidetza–Servicio Vasco de Salud, a través del Hospital Universitario Donostia, ha adjudicado a ABBVIE SPAIN, S.L. el suministro de gel intestinal de levodopa/carbidopa, foslevodopa/foscarbidopa y risankizumab para la provincia de Álava, por cinco años y un valor final de 24.517.875 euros; el valor máximo previsto era de 29.421.449,40 euros. La adjudicación se basó en el mejor precio y se recibió una oferta.
Farmasøytisk engroshandel
Result
- ABBVIE SPAIN, S.L.Winner
- 1Number of tenders received
- €24,517,875Contract value
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Mejor precio
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at OSAKIDETZA - Servicio Vasco de Salud - Hospital Universitario Cruces (Impulsora)
From the notice
Suministro de asociación de Levodopa/Carbidopa (DOE) gel intestinal, asociación Foslevodopa/Foscarbidopa (DOE) y Risankizumab (DOE)Main features of the procedureNegociado Sin Publicidad
Contact
SERVICIO DE FARMACIAcontrata@osakidetza.eus- Result · PrequalificationType
- Araba/ÁlavaLocation
- 33600000Main codePharmaceutical products